A study identified the cell-surface adhesion receptor CD44 as a key positive regulator of PD-L1 expression in triple-negative breast cancer (TNBC) and non-small cell lung cancer (NSCLC)45. The gene discussed is CD44; the disease is triple-negative breast carcinoma.